Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 68083-116

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 68083-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zoledronic-spl-structure (Zoledronic Spl Structure)

Chemical structure diagram of zoledronic acid showing its molecular arrangement with nitrogen-containing ring and phosphonic acid groups.*

FDA Label Image

Zoledronic-spl-fig (Zoledronic Spl Fig)

A bar chart comparing the proportion of complete responders by day 10 in pooled HCM studies between Zoledronic Acid Injection 4 mg and Pamidronate 90 mg. The y-axis shows the percentage of complete responders, with Zoledronic Acid showing a higher percentage (~85%) compared to Pamidronate (~65%). A statistical significance value (P=0.002) is indicated between the two groups.*

FDA Label Image

Zoledronic-spl-vial-label (Zoledronic Spl Vial Label)

Label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL), an intravenous infusion solution. It is a 5 mL single dose vial labeled for dilution prior to infusion, not for direct injection. The label includes storage instructions, manufacturer Gland Pharma Limited, and warnings against mixing with calcium-containing infusions.*

FDA Label Image

Zoledronic-spl-carton-label (Zoledronic Spl Carton Label)

Packaging label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) concentrate for intravenous infusion by Gland Pharma Limited. The box indicates the product is a single-dose vial that requires dilution before infusion and provides storage instructions, ingredients, and warnings about mixing with calcium-containing solutions. The NDC number 68083-116-01 is visible along with manufacturer details and a barcode.*

FDA Label Image

Zoledronic-spl-glass-vial-label (Zoledronic Spl Glass Vial Label)

Label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) concentrate for intravenous infusion by Gland Pharma Limited. The label notes use after dilution, single dose vial, not for direct injection, and storage instructions at 25°C with permissible excursions. It also advises not to mix with calcium-containing infusion solutions and to discard unused portions.*

FDA Label Image

Zoledronic-spl-glass-carton-label (Zoledronic Spl Glass Carton Label)

Packaging label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) concentrate for intravenous infusion by Gland Pharma Limited. The label indicates a single dose 5 mL vial with instructions that the dose must be diluted, is not for direct injection, and should not be mixed with calcium-containing infusion solutions. Storage instructions and a barcode are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.